Advertisement

Topics

GIBRALTAR LABORATORIES, INC. Company Profile

14:01 EDT 25th June 2018 | BioPortfolio

Founded in 1970 by Dr. Herbert Prince, co-discoverer of a cure for Hodgkin's disease (Procarbazine), Gibraltar Laboratories, Inc. (GBL) has over 30 years of exemplary service to its credit. Now with Dr. Daniel Prince at the helm, GBL's eminent scientific staff and stellar track record make it the gold standard of contract labs. It is one of the few labs in the country currently ISO 17025 certified. With labs in New Jersey and a staff of thirty scientists (including two PhD's, one VMD, and three Masters-level microbiologists), companies turn to GBL for the most exacting research, testing, and scientific consulting.

Location

122 Fairfield Road
Fairfield
New Jersey
07004-2405
United States of America

Contact

Phone: 1-973-227-6882
Fax: 1-973-227-0812.
Email: danielprince@gibraltarlabsinc.com


News Articles [235 Associated News Articles listed on BioPortfolio]

Gibraltar Supreme Court Awards Chevron $38 Million Against Ecuadorian Conspirators

The Supreme Court of Gibraltar has issued a judgment against Pablo Fajardo, Luis Yanza, Ermel Chavez, Frente de Defensa de la Amazonia (the "Front") and Servicios Fromboliere for their role in a c...

Gaviria Outsprints the Pack to Stage 1 Victory as 2018 Amgen Tour of California Gets Underway ...

Climbers Primed for Tomorrow’s Anticipated Queen Stage from Ventura to the Top of Gibraltar Road Read more...

Reviewing IDEXX Laboratories (IDXX) & The Competition

IDEXX Laboratories is one of 25 publicly-traded companies in the "Diagnostic substances" industry, but how does it contrast to its rivals? We will compare IDEXX Laboratories to related businesses base...

Reviewing Impax Laboratories

Impax Laboratories and Corcept Therapeutics are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, in...

Critical Comparison: Impax Laboratories

Impax Laboratories and Innocoll are both small-cap pharmaceuticals - nec companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk,...

Zacks: Brokerages Anticipate Impax Laboratories Inc (IPXL) Will Announce Earnings of $0.12 Per Share

Analysts forecast that Impax Laboratories Inc will post earnings per share of $0.12 for the current quarter, Zacks reports. Five analysts have made estimates for Impax Laboratories' earnings.

Brokers Issue Forecasts for Impax Laboratories Inc's Q1 2018 Earnings

Impax Laboratories Inc - Analysts at SunTrust Banks issued their Q1 2018 earnings estimates for Impax Laboratories in a report issued on Wednesday. SunTrust Banks analyst J. Boris expects that the spe...

Bionik Laboratories Issues Letter to Stockholders

I joined Bionik Laboratories as CEO in September 2017, having served as a director of the Company for the previous two months.  A focus Read more...

PubMed Articles [170 Associated PubMed Articles listed on BioPortfolio]

On the Rocks: Using Discourse Analysis to Examine Relationships between Barbary Macaques (Macaca sylvanus) and People on Gibraltar.

Primates are difficult to categorise due to some of the human-like characteristics they possess. Here, we examine the complexities that exist in a commensal relationship between an introduced populati...

Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.

Increasingly used for clinical purposes, genome and exome sequencing can generate clinically relevant information that is not directly related to the reason for testing (incidental or secondary findin...

Cell-Free DNA Analysis in Maternal Blood: Differences in Estimates between Laboratories with Different Methodologies Using a Propensity Score Approach.

To evaluate the failure rate and performance of cell-free DNA (cfDNA) testing, mainly in terms of detection rates for trisomy 21, performed by 2 laboratories using different analytical methods.

The American Society for Clinical Pathology's 2016-2017 Vacancy Survey of Medical Laboratories in the United States.

To determine the extent and distribution of workforce shortages within the nation's medical laboratories.

Mapping of the US Domestic Influenza Virologic Surveillance Landscape.

Influenza virologic surveillance is critical each season for tracking influenza circulation, following trends in antiviral drug resistance, detecting novel influenza infections in humans, and selectin...

Clinical Trials [254 Associated Clinical Trials listed on BioPortfolio]

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fasting c...

Companies [958 Associated Companies listed on BioPortfolio]

GIBRALTAR LABORATORIES, INC.

Founded in 1970 by Dr. Herbert Prince, co-discoverer of a cure for Hodgkin's disease (Procarbazine), Gibraltar Laboratories, Inc. (GBL) has over 30 years of exemplary service to its credit. Now with D...

Gibraltar Business Capital

Headquartered in Chicago, Gibraltar Business Capital is a privately held middle-market lender providing small- to medium-sized business owners fresh and accessible capital alte...

Gibraltar Associates

Bio/Data Corporation

Bio/Data Corporation Specializes In The Development, Production, Marketing And Licensing Of Technologies; Pre-Analytical Sample Preparation Utilizing Microfiltration, Aggregometers, Coagulation Instru...

KENT LABORATORIES

Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

More Information about "GIBRALTAR LABORATORIES, INC." on BioPortfolio

We have published hundreds of GIBRALTAR LABORATORIES, INC. news stories on BioPortfolio along with dozens of GIBRALTAR LABORATORIES, INC. Clinical Trials and PubMed Articles about GIBRALTAR LABORATORIES, INC. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GIBRALTAR LABORATORIES, INC. Companies in our database. You can also find out about relevant GIBRALTAR LABORATORIES, INC. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record